Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?

All drugs have both favorable therapeutic and untoward adverse effects. Conventional opioid analgesics possess both analgesia and adverse reactions, such as nausea, vomiting, and respiratory depression. The opioid ligand binds to µ opioid receptor and non-selectively activates two intracellular sign...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Pain
Egile Nagusiak: Ok, Hwoe Gyeong, Kim, Su Young, Lee, Su Jung, Kim, Tae Kyun, Huh, Billy K, Kim, Kyung Hoon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Pain Society 2018
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5904350/
https://ncbi.nlm.nih.gov/pubmed/29686804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3344/kjp.2018.31.2.73
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak